
MHE October 2023



Laws since 1996 have sought to assure that coverage of behavioral health treatments does not take a back seat to physical medicine. Amid a national crisis in mental illness and addiction, that new world of equality has not arrived. But is it on the way?

Two drugs that target the c-MET protein are in phase 3 trials.

Payers and hospitals are at odds over proposals that would level out payments to hospital outpatient departments and physician offices.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Cigna Announces ‘Rebate-Free’ Pharmacy Benefit Model Starting in 2027
2
Rebates Play a Major Role in Whether Health Plans Restrict Access to Specialty Drugs | AMCP Nexus 2025
3
PBM Reform Debate: Panelists Clash Over Spread Pricing and Rebates | AMCP Nexus 2025
4
Opioid Therapy Overuse in Cancer Survivors: Cost-Inefficient, Poor Health Outcomes | AMCP Nexus 2025
5




